Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.

Levine AP, Chan MMY, Sadeghi-Alavijeh O, Wong EKS, Cook HT, Ashford S, Carss K, Christian MT, Hall M, Harris CL, McAlinden P, Marchbank KJ, Marks SD, Maxwell H, Megy K, Penkett CJ, Mozere M, Stirrups KE, Tuna S, Wessels J, Whitehorn D; MPGN/DDD/C3 Glomerulopathy Rare Disease Group; NIHR BioResource, Johnson SA, Gale DP.

J Am Soc Nephrol. 2020 Jan 9. pii: ASN.2019040433. doi: 10.1681/ASN.2019040433. [Epub ahead of print]

PMID:
31919107
2.

The Leg Activity measure, a new measure of passive and active function and impact on quality of life; informing goal setting and outcome evaluation in leg spasticity.

Ashford SA, Nair A, Hancock D, Orridge S, Williams H, Turner-Stokes L.

Disabil Rehabil. 2019 Dec 4:1-9. doi: 10.1080/09638288.2019.1697765. [Epub ahead of print]

PMID:
31800371
3.

The Genetic Links to Anxiety and Depression (GLAD) Study: Online recruitment into the largest recontactable study of depression and anxiety.

Davies MR, Kalsi G, Armour C, Jones IR, McIntosh AM, Smith DJ, Walters JTR, Bradley JR, Kingston N, Ashford S, Beange I, Brailean A, Cleare AJ, Coleman JRI, Curtis CJ, Curzons SCB, Davis KAS, Dowey LRC, Gault VA, Goldsmith KA, Bennett MH, Hirose Y, Hotopf M, Hübel C, Kanz C, Leng J, Lyall DM, Mason BD, McAtarsney-Kovacs M, Monssen D, Moulton A, Ovington N, Palaiologou E, Pariante CM, Parikh S, Peel AJ, Price RK, Rimes KA, Rogers HC, Sambrook J, Skelton M, Spaul A, Suarez ELA, Sykes BL, Thomas KG, Young AH, Vassos E, Veale D, White KM, Wingrove J; NIHR BioResource consortium, Eley TC, Breen G.

Behav Res Ther. 2019 Dec;123:103503. doi: 10.1016/j.brat.2019.103503. Epub 2019 Oct 24.

4.

Goal-setting and attainment in prolonged disorders of consciousness - development of a structured approach.

Turner-Stokes L, Rose H, Lakra C, Williams H, Ashford SA, Siegert RJ.

Brain Inj. 2020;34(1):78-88. doi: 10.1080/02699052.2019.1682190. Epub 2019 Oct 30.

PMID:
31661982
5.

Psychometric evaluation of the leg activity measure (LegA) for outcome measurement in people with brain injury and spasticity.

Ashford SA, Siegert RJ, Williams H, Nair A, Orridge S, Turner-Stokes L.

Disabil Rehabil. 2019 Jul 22:1-12. doi: 10.1080/09638288.2019.1643933. [Epub ahead of print]

PMID:
31328963
6.

Germline selection shapes human mitochondrial DNA diversity.

Wei W, Tuna S, Keogh MJ, Smith KR, Aitman TJ, Beales PL, Bennett DL, Gale DP, Bitner-Glindzicz MAK, Black GC, Brennan P, Elliott P, Flinter FA, Floto RA, Houlden H, Irving M, Koziell A, Maher ER, Markus HS, Morrell NW, Newman WG, Roberts I, Sayer JA, Smith KGC, Taylor JC, Watkins H, Webster AR, Wilkie AOM, Williamson C; NIHR BioResource–Rare Diseases; 100,000 Genomes Project–Rare Diseases Pilot, Ashford S, Penkett CJ, Stirrups KE, Rendon A, Ouwehand WH, Bradley JR, Raymond FL, Caulfield M, Turro E, Chinnery PF.

Science. 2019 May 24;364(6442). pii: eaau6520. doi: 10.1126/science.aau6520. Epub 2019 May 23.

7.

The money or the morals? When moral language is more effective for selling social issues.

Mayer DM, Ong M, Sonenshein S, Ashford SJ.

J Appl Psychol. 2019 Aug;104(8):1058-1076. doi: 10.1037/apl0000388. Epub 2019 Feb 4.

PMID:
30714748
8.

Preliminary evaluation of the reliability, validity and feasibility of the arm activity measure - Thai version (ArmA-TH) in cerebrovascular patients with upper limb hemiplegia.

Buntragulpoontawee M, Euawongyarti P, Wongpakaran T, Ashford S, Rattanamanee S, Khunachiva J.

Health Qual Life Outcomes. 2018 Jul 16;16(1):141. doi: 10.1186/s12955-018-0971-2.

9.

Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes.

Whitworth J, Smith PS, Martin JE, West H, Luchetti A, Rodger F, Clark G, Carss K, Stephens J, Stirrups K, Penkett C, Mapeta R, Ashford S, Megy K, Shakeel H, Ahmed M, Adlard J, Barwell J, Brewer C, Casey RT, Armstrong R, Cole T, Evans DG, Fostira F, Greenhalgh L, Hanson H, Henderson A, Hoffman J, Izatt L, Kumar A, Kwong A, Lalloo F, Ong KR, Paterson J, Park SM, Chen-Shtoyerman R, Searle C, Side L, Skytte AB, Snape K, Woodward ER; NIHR BioResource Rare Diseases Consortium, Tischkowitz MD, Maher ER.

Am J Hum Genet. 2018 Jul 5;103(1):3-18. doi: 10.1016/j.ajhg.2018.04.013. Epub 2018 Jun 14.

10.

Categorisation of goals set using Goal Attainment Scaling for treatment of leg spasticity: a multicentre analysis.

Ashford S, Williams H, Nair A, Orridge S, Turner-Stokes L.

Disabil Rehabil. 2019 Aug;41(16):1925-1930. doi: 10.1080/09638288.2018.1451927. Epub 2018 Mar 20.

PMID:
29558228
11.

Rasch analysis of the UK Functional Assessment Measure in patients with complex disability after stroke.

Medvedev ON, Turner-Stokes L, Ashford S, Siegert RJ.

J Rehabil Med. 2018 Feb 28. doi: 10.2340/16501977-2324. [Epub ahead of print]

12.

A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework.

Turner-Stokes L, Ashford S, Esquenazi A, Wissel J, Ward AB, Francisco G, Lains J, Suputtitada A, Serrano S, Baguley IJ, Barnes M, Simpson DM.

Eur J Phys Rehabil Med. 2018 Aug;54(4):605-617. doi: 10.23736/S1973-9087.17.04808-0. Epub 2017 Dec 21. Review.

13.

Platelet function is modified by common sequence variation in megakaryocyte super enhancers.

Petersen R, Lambourne JJ, Javierre BM, Grassi L, Kreuzhuber R, Ruklisa D, Rosa IM, Tomé AR, Elding H, van Geffen JP, Jiang T, Farrow S, Cairns J, Al-Subaie AM, Ashford S, Attwood A, Batista J, Bouman H, Burden F, Choudry FA, Clarke L, Flicek P, Garner SF, Haimel M, Kempster C, Ladopoulos V, Lenaerts AS, Materek PM, McKinney H, Meacham S, Mead D, Nagy M, Penkett CJ, Rendon A, Seyres D, Sun B, Tuna S, van der Weide ME, Wingett SW, Martens JH, Stegle O, Richardson S, Vallier L, Roberts DJ, Freson K, Wernisch L, Stunnenberg HG, Danesh J, Fraser P, Soranzo N, Butterworth AS, Heemskerk JW, Turro E, Spivakov M, Ouwehand WH, Astle WJ, Downes K, Kostadima M, Frontini M.

Nat Commun. 2017 Jul 13;8:16058. doi: 10.1038/ncomms16058.

14.

Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity.

Hendricks AE, Bochukova EG, Marenne G, Keogh JM, Atanassova N, Bounds R, Wheeler E, Mistry V, Henning E, Körner A, Muddyman D, McCarthy S, Hinney A, Hebebrand J, Scott RA, Langenberg C, Wareham NJ, Surendran P, Howson JM, Butterworth AS, Danesh J, Nordestgaard BG, Nielsen SF, Afzal S, Papadia S, Ashford S, Garg S, Millhauser GL, Palomino RI, Kwasniewska A, Tachmazidou I, O'Rahilly S, Zeggini E, Barroso I, Farooqi IS; Understanding Society Scientific Group; EPIC-CVD Consortium; UK10K Consortium.

Sci Rep. 2017 Jun 29;7(1):4394. doi: 10.1038/s41598-017-03054-8.

15.

Corrigendum: Common genetic variation drives molecular heterogeneity in human iPSCs.

Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S, Bala S, Bensaddek D, Casale FP, Culley OJ, Danecek P, Faulconbridge A, Harrison PW, Kathuria A, McCarthy D, McCarthy SA, Meleckyte R, Memari Y, Moens N, Soares F, Mann A, Streeter I, Agu CA, Alderton A, Nelson R, Harper S, Patel M, White A, Patel SR, Clarke L, Halai R, Kirton CM, Kolb-Kokocinski A, Beales P, Birney E, Danovi D, Lamond AI, Ouwehand WH, Vallier L, Watt FM, Durbin R, Stegle O, Gaffney DJ.

Nature. 2017 Jun 29;546(7660):686. doi: 10.1038/nature23012. Epub 2017 Jun 14.

PMID:
28614302
16.

Common genetic variation drives molecular heterogeneity in human iPSCs.

Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S, Bala S, Bensaddek D, Casale FP, Culley OJ, Danecek P, Faulconbridge A, Harrison PW, Kathuria A, McCarthy D, McCarthy SA, Meleckyte R, Memari Y, Moens N, Soares F, Mann A, Streeter I, Agu CA, Alderton A, Nelson R, Harper S, Patel M, White A, Patel SR, Clarke L, Halai R, Kirton CM, Kolb-Kokocinski A, Beales P, Birney E, Danovi D, Lamond AI, Ouwehand WH, Vallier L, Watt FM, Durbin R, Stegle O, Gaffney DJ.

Nature. 2017 Jun 15;546(7658):370-375. doi: 10.1038/nature22403. Epub 2017 May 10. Erratum in: Nature. 2017 Jun 29;546(7660):686.

17.

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

Ashford S.

Physiother Res Int. 2017 Apr;22(2). doi: 10.1002/pri.1686. Epub 2017 Mar 9. No abstract available.

PMID:
28276178
18.

Development of a measure of therapy provision for spasticity management in the paretic lower limb - the Leg Therapy recording Schedule (LegTS).

Ashford S, Jackson D, Turner-Stokes L.

Disabil Rehabil. 2018 Feb;40(4):479-485. doi: 10.1080/09638288.2016.1258435. Epub 2016 Dec 7.

PMID:
27927020
19.

Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells.

Chen L, Ge B, Casale FP, Vasquez L, Kwan T, Garrido-Martín D, Watt S, Yan Y, Kundu K, Ecker S, Datta A, Richardson D, Burden F, Mead D, Mann AL, Fernandez JM, Rowlston S, Wilder SP, Farrow S, Shao X, Lambourne JJ, Redensek A, Albers CA, Amstislavskiy V, Ashford S, Berentsen K, Bomba L, Bourque G, Bujold D, Busche S, Caron M, Chen SH, Cheung W, Delaneau O, Dermitzakis ET, Elding H, Colgiu I, Bagger FO, Flicek P, Habibi E, Iotchkova V, Janssen-Megens E, Kim B, Lehrach H, Lowy E, Mandoli A, Matarese F, Maurano MT, Morris JA, Pancaldi V, Pourfarzad F, Rehnstrom K, Rendon A, Risch T, Sharifi N, Simon MM, Sultan M, Valencia A, Walter K, Wang SY, Frontini M, Antonarakis SE, Clarke L, Yaspo ML, Beck S, Guigo R, Rico D, Martens JHA, Ouwehand WH, Kuijpers TW, Paul DS, Stunnenberg HG, Stegle O, Downes K, Pastinen T, Soranzo N.

Cell. 2016 Nov 17;167(5):1398-1414.e24. doi: 10.1016/j.cell.2016.10.026.

20.

Validity, reliability and ease of use of the disabilities of arm, shoulder and hand questionnaire in adults following stroke.

Dalton E, Lannin NA, Laver K, Ross L, Ashford S, McCluskey A, Cusick A.

Disabil Rehabil. 2017 Dec;39(24):2504-2511. doi: 10.1080/09638288.2016.1229364. Epub 2016 Oct 21.

PMID:
27767374
21.

Poster 373-C Integrated Upper Limb Spasticity Management Including Botulinum Toxin A (BoNT-A) on Patient-Centered Goal Attainment: Methodology for ULIS-III and Initial Goal-Setting Data.

Turner-Stokes L, Balcaitiene J, Ashford S, Jacinto J, Maisonobe P, Fheodoroff K.

PM R. 2016 Sep;8(9S):S331. doi: 10.1016/j.pmrj.2016.08.022. Epub 2016 Sep 24. No abstract available.

PMID:
27673269
22.

Poster 313 Relationship Between AbobotulinumtoxinA Injections into Shoulder Muscles and Patient Centred Primary Goal Selection and Achievement: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study.

Jacinto J, Balcaitiene J, Maisonobe P, Fheodoroff K, Ashford S, Turner-Stokes L.

PM R. 2016 Sep;8(9S):S262. doi: 10.1016/j.pmrj.2016.07.483. Epub 2016 Sep 24. No abstract available.

PMID:
27673067
23.

Deviance and exit: The organizational costs of job insecurity and moral disengagement.

Huang GH, Wellman N, Ashford SJ, Lee C, Wang L.

J Appl Psychol. 2017 Jan;102(1):26-42. doi: 10.1037/apl0000158. Epub 2016 Sep 12.

PMID:
27618406
24.

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).

Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K.

BMJ Open. 2016 Jun 17;6(6):e011157. doi: 10.1136/bmjopen-2016-011157.

25.

A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.

Turro E, Greene D, Wijgaerts A, Thys C, Lentaigne C, Bariana TK, Westbury SK, Kelly AM, Selleslag D, Stephens JC, Papadia S, Simeoni I, Penkett CJ, Ashford S, Attwood A, Austin S, Bakchoul T, Collins P, Deevi SV, Favier R, Kostadima M, Lambert MP, Mathias M, Millar CM, Peerlinck K, Perry DJ, Schulman S, Whitehorn D, Wittevrongel C; BRIDGE-BPD Consortium, De Maeyer M, Rendon A, Gomez K, Erber WN, Mumford AD, Nurden P, Stirrups K, Bradley JR, Raymond FL, Laffan MA, Van Geet C, Richardson S, Freson K, Ouwehand WH.

Sci Transl Med. 2016 Mar 2;8(328):328ra30. doi: 10.1126/scitranslmed.aad7666. Epub 2016 Mar 2.

26.

A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.

Stritt S, Nurden P, Turro E, Greene D, Jansen SB, Westbury SK, Petersen R, Astle WJ, Marlin S, Bariana TK, Kostadima M, Lentaigne C, Maiwald S, Papadia S, Kelly AM, Stephens JC, Penkett CJ, Ashford S, Tuna S, Austin S, Bakchoul T, Collins P, Favier R, Lambert MP, Mathias M, Millar CM, Mapeta R, Perry DJ, Schulman S, Simeoni I, Thys C; BRIDGE-BPD Consortium, Gomez K, Erber WN, Stirrups K, Rendon A, Bradley JR, van Geet C, Raymond FL, Laffan MA, Nurden AT, Nieswandt B, Richardson S, Freson K, Ouwehand WH, Mumford AD.

Blood. 2016 Jun 9;127(23):2903-14. doi: 10.1182/blood-2015-10-675629. Epub 2016 Feb 24.

27.

Conceptualization and Development of the Leg Activity Measure (LegA) for Patient and Carer Reported Assessment of Activity in the Paretic Leg.

Ashford S, Jackson D, Mahaffey P, Vanderstay R, Turner-Stokes L.

Physiother Res Int. 2017 Apr;22(2). doi: 10.1002/pri.1660. Epub 2016 Feb 16.

PMID:
26881807
28.

Common goal areas in the treatment of upper limb spasticity: a multicentre analysis.

Ashford S, Fheodoroff K, Jacinto J, Turner-Stokes L.

Clin Rehabil. 2016 Jun;30(6):617-22. doi: 10.1177/0269215515593391. Epub 2015 Jul 3. Review.

PMID:
26141809
29.

A systematic review protocol to evaluate the psychometric properties of measures of function within adult neuro-rehabilitation.

Pike S, Lannin NA, Cusick A, Wales K, Turner-Stokes L, Ashford S.

Syst Rev. 2015 Jun 13;4:86. doi: 10.1186/s13643-015-0076-5.

30.

Rasch measurement: the Arm Activity measure (ArmA) passive function sub-scale.

Ashford S, Siegert RJ, Alexandrescu R.

Disabil Rehabil. 2016;38(4):384-90. doi: 10.3109/09638288.2015.1041613. Epub 2015 Apr 28.

PMID:
25918961
31.

Serial measurement of Wessex Head Injury Matrix in the diagnosis of patients in vegetative and minimally conscious states: a cohort analysis.

Turner-Stokes L, Bassett P, Rose H, Ashford S, Thu A.

BMJ Open. 2015 Apr 21;5(4):e006051. doi: 10.1136/bmjopen-2014-006051.

32.
33.

Job insecurity and organizational citizenship behavior: exploring curvilinear and moderated relationships.

Lam CF, Liang J, Ashford SJ, Lee C.

J Appl Psychol. 2015 Mar;100(2):499-510. doi: 10.1037/a0038659. Epub 2015 Jan 19.

PMID:
25602119
34.

PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43.

Joardar A, Menzl J, Podolsky TC, Manzo E, Estes PS, Ashford S, Zarnescu DC.

Hum Mol Genet. 2015 Mar 15;24(6):1741-54. doi: 10.1093/hmg/ddu587. Epub 2014 Nov 28.

35.

Systematic review of patient-reported outcome measures for functional performance in the lower limb.

Ashford S, Brown S, Turner-Stokes L.

J Rehabil Med. 2015 Jan;47(1):9-17. doi: 10.2340/16501977-1889. Review.

36.

Goal setting, using goal attainment scaling, as a method to identify patient selected items for measuring arm function.

Ashford S, Jackson D, Turner-Stokes L.

Physiotherapy. 2015 Mar;101(1):88-94. doi: 10.1016/j.physio.2014.04.001. Epub 2014 Apr 18.

PMID:
24954806
37.

Osteoarthritis: A review.

Ashford S, Williard J.

Nurse Pract. 2014 May 12;39(5):1-8. doi: 10.1097/01.NPR.0000445886.71205.c4. Review.

PMID:
24739424
38.

KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation.

Pearce LR, Atanassova N, Banton MC, Bottomley B, van der Klaauw AA, Revelli JP, Hendricks A, Keogh JM, Henning E, Doree D, Jeter-Jones S, Garg S, Bochukova EG, Bounds R, Ashford S, Gayton E, Hindmarsh PC, Shield JP, Crowne E, Barford D, Wareham NJ; UK10K consortium, O'Rahilly S, Murphy MP, Powell DR, Barroso I, Farooqi IS.

Cell. 2013 Nov 7;155(4):765-77.

39.

NICE on rehabilitation. New guidelines on rehabilitation likely to restrict practices and stifle innovation.

Pandyan AD, Radford K, Ashford S, Bateman A, Burton C, Connell L, Gibson A, Harris N, Hoffman K, Nair R, Shaw L, Turton A, Tyson SF, van Wijck F.

BMJ. 2013 Aug 6;347:f4876. doi: 10.1136/bmj.f4876. No abstract available.

PMID:
23920259
40.

Reducing job insecurity and increasing performance ratings: does impression management matter?

Huang GH, Zhao HH, Niu XY, Ashford SJ, Lee C.

J Appl Psychol. 2013 Sep;98(5):852-62. doi: 10.1037/a0033151. Epub 2013 Jun 3. Erratum in: J Appl Psychol. 2014 Jan;99(1):86.

PMID:
23731028
41.

Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.

Ashford S, Turner-Stokes L.

Physiother Res Int. 2013 Sep;18(3):178-89. doi: 10.1002/pri.1554. Epub 2013 Apr 30. Review.

PMID:
23630050
42.

Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm.

Ashford S, Turner-Stokes L, Siegert R, Slade M.

Clin Rehabil. 2013 Aug;27(8):728-40. doi: 10.1177/0269215512474942. Epub 2013 Feb 20.

PMID:
23426566
43.

Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm.

Ashford S, Slade M, Turner-Stokes L.

Disabil Rehabil. 2013 Aug;35(18):1513-8. doi: 10.3109/09638288.2012.743602. Epub 2013 Jan 7.

44.

Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease.

Ricketts SL, Rensing KL, Holly JM, Chen L, Young EH, Luben R, Ashford S, Song K, Yuan X, Dehghan A, Wright BJ, Waterworth DM, Mooser V; GEMS Investigators, Waeber G, Vollenweider P, Epstein SE, Burnett MS, Devaney JM, Hakonarson HH, Rader DJ, Reilly MP, Danesh J, Thompson SG, Dunning AM, van Duijn CM, Samani NJ, McPherson R, Wareham NJ, Khaw KT, Boekholdt SM, Sandhu MS.

Int J Mol Epidemiol Genet. 2011 Aug 30;2(3):261-85. Epub 2011 Aug 3.

45.

A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy.

Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French DP.

Psychol Health. 2011 Nov;26(11):1479-98. doi: 10.1080/08870446.2010.540664. Epub 2011 Jun 28.

PMID:
21678185
46.

Feedback and the rationing of time and effort among competing tasks.

Northcraft GB, Schmidt AM, Ashford SJ.

J Appl Psychol. 2011 Sep;96(5):1076-86. doi: 10.1037/a0023221.

PMID:
21463017
47.

Genetic variants influencing circulating lipid levels and risk of coronary artery disease.

Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N, Luan J, Ashford S, Wheeler E, Young EH, Hadley D, Thompson JR, Braund PS, Johnson T, Struchalin M, Surakka I, Luben R, Khaw KT, Rodwell SA, Loos RJ, Boekholdt SM, Inouye M, Deloukas P, Elliott P, Schlessinger D, Sanna S, Scuteri A, Jackson A, Mohlke KL, Tuomilehto J, Roberts R, Stewart A, Kesäniemi YA, Mahley RW, Grundy SM; Wellcome Trust Case Control Consortium, McArdle W, Cardon L, Waeber G, Vollenweider P, Chambers JC, Boehnke M, Abecasis GR, Salomaa V, Järvelin MR, Ruokonen A, Barroso I, Epstein SE, Hakonarson HH, Rader DJ, Reilly MP, Witteman JC, Hall AS, Samani NJ, Strachan DP, Barter P, van Duijn CM, Kooner JS, Peltonen L, Wareham NJ, McPherson R, Mooser V, Sandhu MS.

Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2264-76. doi: 10.1161/ATVBAHA.109.201020. Epub 2010 Sep 23.

48.

Knowledge of motivational interviewing.

Goodwin AC, Bar BB, Reid GG, Ashford SA.

J Holist Nurs. 2009 Sep;27(3):203-9. doi: 10.1177/0898010109333335.

PMID:
19755568
49.

What is the best way to change self-efficacy to promote lifestyle and recreational physical activity? A systematic review with meta-analysis.

Ashford S, Edmunds J, French DP.

Br J Health Psychol. 2010 May;15(Pt 2):265-88. doi: 10.1348/135910709X461752. Epub 2009 Jul 7. Review.

PMID:
19586583
50.

Evaluation of functional outcome measures for the hemiparetic upper limb: a systematic review.

Ashford S, Slade M, Malaprade F, Turner-Stokes L.

J Rehabil Med. 2008 Nov;40(10):787-95. doi: 10.2340/16501977-0276. Review.

Supplemental Content

Loading ...
Support Center